Fritextsökning
Innehållstyper
-
Fler nya substanser
40 procent av de läkemedel som rekommenderades för godkännande av EMA år 2015 har en ny aktiv substans.
-
Namn på ersättningsläkemedel kan förvirra
Ersättningsmediciner är bra för landstingens ekonomi. Men samtidigt riskerar patienter att inte känna igen sina mediciner, när det står andra namn på förpacknin...
-
Hamlet sluter avtal med klinisk prövare
Hamlet Pharma har idag slutit avtal med klinisk prövare i den kommande fas II-studien där bröstmjölksmolekylen Halmet testas mot blåscancer.
-
Efter studien: ”Vi har bäst kombination av effekt och säkerhet”
– Nu förbereder vi oss för fas III, säger vd Peter Zerhouni efter att Index pharmaceuticals når målen i fas IIb-studien med sin läkemedelskandidat mot ulcerös kolit.
-
Bioventure hub blir dubbelt så stort
Life science-företagsparken i Astrazenecas lokaler i Mölndal fördubblar sin yta.
-
Han tar plats i life science-gruppen
Hjärnforskaren Thomas Insel ska hjälpa Googles life science-grupp med utvecklingen av tekniker för mentala sjukdomar.
-
Rapid system for surface hygiene monitoring
The Clean-Trace Surface Testing Instruments are a rapid solution to monitor biological contamination on surfaces in real time to help customers manage their cle...
-
Academia - a strong player on the lab market
While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia incre...
-
Fewer visitors but satisfied exhibitors
Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.
-
Showroom for free
The latest equipment with trained staff. Sci Life Lab in Stockholm want to offer top conditions at the new imaging laboratory. But some vendors are skeptical to...
-
Index startar tarmstudie i fas III
Ska testa nytt preparat mot ulcerös kolit.
-
Prisar alzheimerforskare
KI-professorn Miia Kivipelto tilldelas Alzheimerfondens stora forskningspris.
-
New automated solution for flexible molecular assays
The fully integrated Qiasymphony is a new automated platform for flexible molecular testing.
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...
-
USB recycler for liquid chromatography
The Smartsaver recycler from Biotech AB is designed to recycle the uncontaminated mobile phase in isocratic liquid chromatography.
-
Laboratory food
VWR exhibits laboratory tools with molecular gastronomy Rotary evaporators and magnetic stirrers - for making food. VWR tries out new ways for the exhibition at...
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Changing e-solutions for clinical trials
Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...
-
Reproducibility and handling in focus with new electronic pipette
The Eppendorf Xplorer electronic pipette has been developed with reproducibility in mind.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Take off for this year's fair
More visitors than previously were preregistered when Scanlab and Biotech Forum opened today. But the future of the exhibitions and their design is uncertain.
-
Förklarar forskning med animerad film
Tecknade filmer ska förklara avancerad vetenskap för barn och för allmänheten. Det är förhoppningen med the Fair Journal, en vetenskaplig tidskrift som grundats...
-
This is Sweden's largest life science region
About 60 percent of all jobs within swedish life science are found in the Stockholm-Uppsala area. This was stated in a report presented at Scanlab & Biotech Forum today.